Kalfa, Theodosia
Cincinnati Children's Hospital Medical Center · University of Cincinnati · University of Cincinnati Medical Center
4 papers on CoChatORCID 0000-0002-0426-9686
Most cited papers
- Verified
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 515
- Verified
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia
McGann, P. T., Niss, O., Dong, M., Marahatta, A., Howard, T. A., Mizuno, T., Lane, A., Kalfa, T. A., Malik, P., Quinn, C. T., et al. (2019) · American Journal of Hematology
Hemoglobinopathies and Related DisordersPharmaceutical studies and practices
Cited by 105
- Verified
Effects of hydroxyurea treatment for patients with hemoglobin SC disease
Luchtman‐Jones, L., Pressel, S., Hilliard, L., Brown, R. C., Smith, M. G., Thompson, A. A., Lee, M. T., Rothman, J., Rogers, Z. R., Owen, W., et al. (2016) · American Journal of Hematology
Hemoglobinopathies and Related DisordersHemophilia Treatment and Research
Cited by 86
- Verified
The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress
Daria, D., Filippi, M.-D., Knudsen, E. S., Faccio, R., Li, Z., Kalfa, T., & Geiger, H. (2008) · Blood
Hematopoietic Stem Cell TransplantationBlood disorders and treatments
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free